Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Virpax Pharmaceuticals (VRPX) Stock Price & Analysis

VRPX Stock Chart & Stats

$0.16$0.00(0.00%)
At close: 4:00 PM EDT
$0$0.05$0.1$0.159 Jul10 Jul17 Sep28 Sep
Day’s Range
$0.16 - $0.21
52-Week Range
$0.01 - $0.21
Previous Close
$0.16
Volume
440.71K
Average Volume (3M)
207
Market Cap
$994
Enterprise Value
$4.14M
Total Cash (Recent Filing)
$1.51M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
0.0
Beta
-18790.74
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strategic Partnerships

Strategic partnerships and licensing agreements can provide a steady revenue stream and facilitate product development, enhancing long-term growth potential.

Innovative Drug Delivery Systems

The focus on innovative drug delivery systems positions Virpax to improve therapeutic outcomes, potentially capturing market share in pain management and neurological disorders.

Experienced Leadership

The addition of experienced leadership can strengthen strategic oversight and governance, aiding in navigating regulatory challenges and enhancing operational effectiveness.

Bears Say

Financial Instability

Negative equity and financial instability pose significant risks to operational continuity, requiring urgent strategic pivots or capital injections to sustain business operations.

Zero Revenue

The absence of revenue generation highlights the pre-commercial stage of the company, increasing reliance on external financing and posing long-term sustainability challenges.

Leadership Changes

Frequent leadership changes can disrupt strategic direction and operational stability, potentially impacting investor confidence and the company's ability to execute its business plan.

Virpax Pharmaceuticals News

VRPX FAQ

What was Virpax Pharmaceuticals’s price range in the past 12 months?
Virpax Pharmaceuticals lowest stock price was $0.01 and its highest was $0.21 in the past 12 months.
What is Virpax Pharmaceuticals’s market cap?
Virpax Pharmaceuticals’s market cap is $994.
When is Virpax Pharmaceuticals’s upcoming earnings report date?
Virpax Pharmaceuticals’s next earnings report is estimated for May 19, 2025 (not yet confirmed), which is 532 days ago.
How were Virpax Pharmaceuticals’s earnings last quarter?
Virpax Pharmaceuticals released its earnings results on Mar 26, 2025. The company reported -$5.693 earnings per share for the quarter, beating the consensus estimate of -$9.25 by $3.557.
Is Virpax Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Virpax Pharmaceuticals pay dividends?
Virpax Pharmaceuticals does not currently pay dividends.
What is Virpax Pharmaceuticals’s EPS estimate?
Virpax Pharmaceuticals’s EPS estimate is -5.25.
How many shares outstanding does Virpax Pharmaceuticals have?
Virpax Pharmaceuticals has 1,242,504 shares outstanding.
What happened to Virpax Pharmaceuticals’s price movement after its last earnings report?
Virpax Pharmaceuticals reported an EPS of -$5.693 in its last earnings report, beating expectations of -$9.25. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Virpax Pharmaceuticals?
Currently, no hedge funds are holding shares in VRPX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology